Cargando…
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
INTRODUCTION: It is important to understand which biological processes change with aging, and how such changes are associated with increased Alzheimer's disease (AD) risk. We studied how cerebrospinal fluid (CSF) proteomics changed with age and tested if associations depended on amyloid status,...
Autores principales: | Wesenhagen, Kirsten E.J., Gobom, Johan, Bos, Isabelle, Vos, Stephanie J.B., Martinez‐Lage, Pablo, Popp, Julius, Tsolaki, Magda, Vandenberghe, Rik, Freund‐Levi, Yvonne, Verhey, Frans, Lovestone, Simon, Streffer, Johannes, Dobricic, Valerija, Bertram, Lars, Blennow, Kaj, Pikkarainen, Maria, Hallikainen, Merja, Kuusisto, Johanna, Laakso, Markku, Soininen, Hilkka, Scheltens, Philip, Zetterberg, Henrik, Teunissen, Charlotte E., Visser, Pieter Jelle, Tijms, Betty M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074716/ https://www.ncbi.nlm.nih.gov/pubmed/35571963 http://dx.doi.org/10.1002/dad2.12286 |
Ejemplares similares
-
Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
por: Willemse, Eline A. J., et al.
Publicado: (2021) -
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021) -
Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?
por: Del Campo Milan, Marta, et al.
Publicado: (2015) -
The relationship between cerebrospinal fluid tau markers, hippocampal volume, and delayed primacy performance in cognitively intact elderly individuals
por: Bruno, Davide, et al.
Publicado: (2015) -
Pre‐analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
por: Hansson, Oskar, et al.
Publicado: (2020)